20 Mar 2019 | 7:24 AM
 

Glenmark Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532296 | NSE Symbol: GLENMARK
646.71
3.40
(0.53 %)
19 Mar 2019 | 11:51 AM
Change company
  • Open (Rs)
    642.75
  • Prev. close (Rs.)
    643.30
  • High (Rs.)
    651.30
  • Low (Rs.)
    641.35
  • 52W H (Rs.)
    706.90
  • 52W L (Rs.)
    483.60
  • Volume
    11925
  • MCap (Rs in Cr.)
    18,247.81
651.6
12.15
(1.90 %)
  • Open (Rs)
    640.05
  • High (Rs)
    652.50
  • Low (Rs)
    639.00
  • Prev. close(Rs)
    639.45
  • Contracts Tra.
    14,10,000
  • Turnover (Cr.)
    91
  • Open Interest
    9,00,000
  • Open Int. chg
    -9,40,000.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
28.49
Operating Margin (%)
17.80
Gross Profit Margin (%)
14.47
Net Profit Margin (%)
8.85
Total Debt/Equity
0.86
Dividend payout Ratio (Net Profit)
8.44
Earning Retention Ratio
91.56

News

06 Feb 2019 - 16:58:00-Drug firm Glenmark Pharmaceuticals Wednesday said its Swiss arm has entered into an exclusive licens...
08 Jan 2019 - 17:13:00-Glenmark Pharmaceuticals is targeting a consolidated revenue growth of up to 15 per cent over the ne...
20 Nov 2018 - 13:20:00-Glenmark Pharmaceuticals Tuesday said it has received approval from the US health regulator for Azel...
16 Nov 2018 - 14:29:00-Glenmark Pharmaceuticals Friday said it has received approval from the US health regulator for Terif...

Announcements

15-Mar-2019
Glenmark Pharma - Press Release
15-Mar-2019
Glenmark gets ANDA nod for Clindamycin and Benzoyl Peroxide Gel
15-Mar-2019
Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
07-Mar-2019
Glenmark Pharma - Reply to Clarification Sought
06-Mar-2019
Glenmark Pharma - Clarification

Religare Research

28 Feb 2019 | 10:15 AM
• Agri markets kept trading with high volatility with no strong directions, even as prices seem to f...
04 Feb 2019 | 11:57 AM
Agri Fundamental & Technical Report
21 Jan 2019 | 07:35 PM
Weekly report
07 Jan 2019 | 06:56 PM
Gold prices fell on Friday, pulling back from more than a six-month peak hit earlier in the session,...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
10,00,000 115.06 68.93 -7.91
10,00,000 115.06 59.53 -0.10
10,00,000 115.06 208.92 -0.10
10,00,000 115.06 220.42 -0.09
10,00,000 115.06 73.87 -7.42

Shareholding Pattern

       
Promotors46.54%
Mutual Funds/UTI4.02%
FI/Banks2.91%
Insurance2.91%
FII32.27%
Government0.00%
Others4.92%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
7,386.45(0.62)
3280
 Sanofi India Ltd.
5,560.55(-0.80)
3325
 Pfizer Ltd.
3,224.00(-0.12)
3370
 Dr. Reddy`s Laboratories Ltd.
2,713.00(1.63)
3294

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Glenmark Pharmaceuticals Ltd.70.30-40.10-34.40
NIFTY(S&P CNX)832.70564.95194.75
BSE SENSEX2,655.161,806.52862.93
BSE 5001,237.14559.03-105.87

Corporate Details

Key Personal
B E Saldanha
Non Executive Director
Bernard Munos
Non Exe. & Ind. Director
Brian W Tempest
Non Exe. & Ind. Director
Key Address
Registered Office
B/2 Mahalaxmi Chambers 22 Bhulabhai Desai Road,Mumbai,Maharashtra

Tel:022-40189999 40189879, Fax:022-40189986

csr@glenmarkpharma.com
http://www.glenmarkpharma.com
Registrar Office
Karvy Fintech Pvt. Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda Serilingampally Mandal